Literature DB >> 20163248

Evaluation of hydrodynamic limb vein injections in nonhuman primates.

Julia O Hegge1, Christine I Wooddell, Guofeng Zhang, James E Hagstrom, Serge Braun, Thierry Huss, Magdolna G Sebestyén, Marina E Emborg, Jon A Wolff.   

Abstract

The administration route is emerging as a critical aspect of nonviral and viral vector delivery to muscle, so as to enable gene therapy for disorders such as muscular dystrophy. Although direct intramuscular routes were used initially, intravascular routes are garnering interest because of their ability to target multiple muscles at once and to increase the efficiency of delivery and expression. For the delivery of naked plasmid DNA, our group has developed a hydrodynamic, limb vein procedure that entails placing a tourniquet over the proximal part of the target limb to block all blood flow and injecting the gene vector rapidly in a large volume so as to enable the gene vector to be extravasated and to access the myofibers. The present study was conducted in part to optimize the procedure in preparation for a human clinical study. Various injection parameters such as the effect of papaverine preinjection, tourniquet inflation pressure and duration, and rate of injection were evaluated in rats and nonhuman primates. In addition, the safety of the procedure was further established by determining the effect of the procedure on the neuromuscular and vascular systems. The results from these studies provide additional evidence that the procedure is well tolerated and they provide a foundation on which to formulate the procedure for a human clinical study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163248      PMCID: PMC2938361          DOI: 10.1089/hum.2009.172

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  33 in total

1.  Comparison of ketamine versus combination of ketamine and medetomidine in injectable anesthetic protocols: chemical immobilization in macaques and tissue reaction in rats.

Authors:  Francis J Sun; Douglas E Wright; David M Pinson
Journal:  Contemp Top Lab Anim Sci       Date:  2003-07

2.  Capillary density in skeletal muscle of Wistar rats as a function of muscle weight and body weight.

Authors:  J Browning; N Hogg; G Gobé; R Cross
Journal:  Microvasc Res       Date:  1996-11       Impact factor: 3.514

3.  Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates.

Authors:  G Zhang; V Budker; P Williams; V Subbotin; J A Wolff
Journal:  Hum Gene Ther       Date:  2001-03-01       Impact factor: 5.695

4.  Biomechanics of skeletal muscle capillaries: hemodynamic resistance, endothelial distensibility, and pseudopod formation.

Authors:  J Lee; G W Schmid-Schönbein
Journal:  Ann Biomed Eng       Date:  1995 May-Jun       Impact factor: 3.934

5.  Recombinant adeno-associated virus for muscle directed gene therapy.

Authors:  K J Fisher; K Jooss; J Alston; Y Yang; S E Haecker; K High; R Pathak; S E Raper; J M Wilson
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

6.  Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.

Authors:  W K Cho; S Ebihara; J Nalbantoglu; R Gilbert; B Massie; P Holland; G Karpati; B J Petrof
Journal:  Hum Gene Ther       Date:  2000-03-20       Impact factor: 5.695

7.  Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle.

Authors:  H L Davis; B A Demeneix; B Quantin; J Coulombe; R G Whalen
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

8.  Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.

Authors:  Chunping Qiao; Juan Li; Hui Zheng; Janet Bogan; Jianbin Li; Zhenhua Yuan; Cheng Zhang; Dan Bogan; Joe Kornegay; Xiao Xiao
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

9.  Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.

Authors:  T Ragot; N Vincent; P Chafey; E Vigne; H Gilgenkrantz; D Couton; J Cartaud; P Briand; J C Kaplan; M Perricaudet
Journal:  Nature       Date:  1993-02-18       Impact factor: 49.962

10.  Wallerian degeneration in human nerves: serial electrophysiological studies.

Authors:  V Chaudhry; D R Cornblath
Journal:  Muscle Nerve       Date:  1992-06       Impact factor: 3.217

View more
  12 in total

Review 1.  Gene therapy for muscular dystrophy: moving the field forward.

Authors:  Samiah Al-Zaidy; Louise Rodino-Klapac; Jerry R Mendell
Journal:  Pediatr Neurol       Date:  2014-08-07       Impact factor: 3.372

Review 2.  Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

Authors:  Christophe Pichavant; Annemieke Aartsma-Rus; Paula R Clemens; Kay E Davies; George Dickson; Shin'ichi Takeda; Steve D Wilton; Jon A Wolff; Christine I Wooddell; Xiao Xiao; Jacques P Tremblay
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

3.  Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.

Authors:  Christine I Wooddell; Julia O Hegge; Guofeng Zhang; Magdolna G Sebestyén; Mark Noble; Jacob B Griffin; Loretta V Pfannes; Hans Herweijer; James E Hagstrom; Serge Braun; Thierry Huss; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2011-04-18       Impact factor: 5.695

4.  Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

5.  Selective attachment of a microtubule interacting peptide to plasmid DNA via a triplex forming oligonucleotide for transfection improvement.

Authors:  Caroline Girardin; Delphine Maze; Cristine Gonçalves; Yann Thierry Le Guen; Kevin Pluchon; Chantal Pichon; Tristan Montier; Patrick Midoux
Journal:  Gene Ther       Date:  2022-07-07       Impact factor: 5.250

6.  High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Yasheng Chen; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Hum Gene Ther       Date:  2015-07-30       Impact factor: 5.695

7.  Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease.

Authors:  B Sun; S Li; A Bird; D D Koeberl
Journal:  Gene Ther       Date:  2010-08-05       Impact factor: 5.250

8.  Autophagy as a new therapeutic target in Duchenne muscular dystrophy.

Authors:  C De Palma; F Morisi; S Cheli; S Pambianco; V Cappello; M Vezzoli; P Rovere-Querini; M Moggio; M Ripolone; M Francolini; M Sandri; E Clementi
Journal:  Cell Death Dis       Date:  2012-11-15       Impact factor: 8.469

9.  Condensation of plasmid DNA enhances mitochondrial association in skeletal muscle following hydrodynamic limb vein injection.

Authors:  Yukari Yasuzaki; Yuma Yamada; Yutaka Fukuda; Hideyoshi Harashima
Journal:  Pharmaceuticals (Basel)       Date:  2014-08-21

10.  A targeted controlled force injection of genetic material in vivo.

Authors:  Gustaf Ahlén; Lars Frelin; Fredrik Holmström; Grant Smetham; Steve Augustyn; Matti Sällberg
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.